Literature DB >> 6456099

Strain dependency of the transfer of experimental immune insulitis in mice.

U Kiesel, H Kolb, G Freytag.   

Abstract

Multiple treatment with low doses of streptozotocin induces hyperglycaemia with concomitant lymphocytic infiltrations into pancreatic islets (insulitis) in several mouse strains. The transfer of cellular immune reactions against islet cells by means of spleen cells was tested in two congeneic and five allogeneic strain combinations. Donor mice were treated on 5 consecutive days with 40 mg streptozotocin per kg body weight. Three weeks later, 5 x 10(7) live spleen cells were transferred into thymusless recipient mice. Insulitis which had developed in about 70% of the donors was only transferable from C57B1/6J to congeneic thymusless mice. In a second congeneic and in all allogeneic strain combinations, cellular immune reactions against pancreatic islets could not be transferred. In none of the recipients of spleen cells from diabetic donors was hyperglycaemia observed. As streptozotocin-induced cellular immune reactions against pancreatic islet cells were only transferable in one congeneic and in no allogeneic strain combinations, it is concluded that there is a genetic restriction both on the levels of donor and recipient mice.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6456099      PMCID: PMC1537286     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  8 in total

1.  Complete protection from low-dose streptozotocin-induced diabetes in mice.

Authors:  A A Rossini; R M Williams; M C Appel; A A Like
Journal:  Nature       Date:  1978-11-09       Impact factor: 49.962

2.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

3.  Passive transfer of streptozotocin induced diabetes mellitus with spleen cells. Studies of synogeneic and allogeneic transfer to normal and athymic nude mice.

Authors:  K Buschard; J Rygaard
Journal:  Acta Pathol Microbiol Scand C       Date:  1977-12

4.  Streptozotocin-induced diabetes in athymic and conventional BALB/c mice.

Authors:  G Beattie; R Lannom; J Lipsick; N O Kaplan; A G Osler
Journal:  Diabetes       Date:  1980-02       Impact factor: 9.461

5.  Genetic influence of the streptozotocin-induced insulitis and hyperglycemia.

Authors:  A A Rossini; M C Appel; R M Williams; A A Like
Journal:  Diabetes       Date:  1977-10       Impact factor: 9.461

6.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.

Authors:  A A Like; A A Rossini
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

7.  Cellular immune reactions against pancreatic islets as a consequence of graft versus host disease.

Authors:  H Kolb; G Freytag; U Kiesel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

8.  Spontaneous autoimmune reactions against pancreatic islets in mouse strains with generalized autoimmune disease.

Authors:  H Kolb; G Freytag; U Kiesel; V Kolb-Bachofen
Journal:  Diabetologia       Date:  1980-09       Impact factor: 10.122

  8 in total
  8 in total

Review 1.  Do post-translational beta cell protein modifications trigger type 1 diabetes?

Authors:  Joachim Størling; Anne Julie Overgaard; Caroline Anna Brorsson; Francesco Piva; Claus Heiner Bang-Berthelsen; Claus Haase; Jørn Nerup; Flemming Pociot
Journal:  Diabetologia       Date:  2013-09-19       Impact factor: 10.122

2.  In vivo microscopy of murine islets of Langerhans: increased adhesion of transferred lymphocytes to islets depends on macrophage-derived cytokines in a model of organ-specific insulitis.

Authors:  R Ludwig; M Kretschmer; G Caspar; J Bojunga; A Oldenburg; P Schumm-Draeger; M Stegmüller; G von Minckwitz; K H Usadel; K Kusterer
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

3.  Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.

Authors:  R C McEvoy; J Andersson; S Sandler; C Hellerström
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

4.  Irradiation protects against pancreatic islet degeneration and hyperglycaemia following streptozotocin treatment of mice.

Authors:  M Nedergaard; J Egeberg; H Kromann
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

5.  Immunological transmission of glomerulosclerotic changes in KK-mice with spontaneous diabetes. 1. Transplantation of spleen cells.

Authors:  H Wehner; I König
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

6.  Augmentation of streptozotocin-induced hyperglycemia in mice by prior treatment with complete Freund's adjuvant.

Authors:  K D Kohnert; B Ziegler; K Fält; M Ziegler
Journal:  Int J Pancreatol       Date:  1989-04

7.  The low dose streptozotocin murine model of type 1 (insulin-dependent) diabetes mellitus: studies in vivo and in vitro of the modulating effect of sex hormones.

Authors:  H Kromann; M Christy; A Lernmark; M Nedergaard; J Nerup
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

8.  Low-dose streptozotocin-induced autoimmune diabetes is under the genetic control of the major histocompatibility complex in mice.

Authors:  U Kiesel; H Kolb
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.